Dr. Manmeet Mangat, MD
What this data tells you about Dr. Mangat
Dr. Manmeet Mangat is a hospitalist physician in Midland, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mangat performed 57,981 Medicare services across 3,302 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mangat received a total of $14,677 from 32 pharmaceutical and/or device companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mangat is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Oxaliplatin chemotherapy injection | 12,160 | $0 | $33 |
| Pembrolizumab injection (Keytruda) | 9,700 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 9,300 | $0 | $5 |
| Paclitaxel chemotherapy injection | 6,576 | $0 | $8 |
| Darbepoetin injection (Aranesp) for anemia | 3,300 | $2 | $20 |
| Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 2,870 | $22 | $155 |
| Dexamethasone injection (steroid) | 2,093 | $0 | $1 |
| Blood draw (venipuncture) | 1,381 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,285 | $8 | $36 |
| Comprehensive metabolic blood panel | 1,156 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 870 | $1 | $114 |
| Injection, fluorouracil, 500 mg | 854 | $2 | $13 |
| Injection, leucovorin calcium, per 50 mg | 755 | $3 | $25 |
| Office visit, established patient (20-29 min) | 661 | $59 | $250 |
| Injection, granisetron hydrochloride, 100 mcg | 660 | $0 | $24 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 422 | $21 | $157 |
| Office visit, established patient (30-39 min) | 402 | $93 | $368 |
| Administration of chemotherapy into vein, 1 hour or less | 382 | $96 | $707 |
| Reticulated (young) platelet measurement | 201 | $34 | $143 |
| Injection, carboplatin, 50 mg | 193 | $2 | $300 |
| Injection, zoledronic acid, 1 mg | 176 | $7 | $431 |
| Administration of chemotherapy into vein, each additional hour | 148 | $21 | $161 |
| Lactate dehydrogenase (enzyme) level | 131 | $6 | $31 |
| Injection of additional new drug or substance into vein | 131 | $11 | $108 |
| Administration of additional new drug or substance into vein, 1 hour or less | 120 | $49 | $344 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $131 | $3,675 |
| Injection, diphenhydramine hcl, up to 50 mg | 105 | $1 | $7 |
| Drug injection, under skin or into muscle | 100 | $10 | $96 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 83 | $55 | $211 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 81 | $70 | $70 |
| Ferritin level test (iron stores) | 78 | $13 | $60 |
| Iron level test | 78 | $6 | $27 |
| Iron binding capacity test | 78 | $9 | $35 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 76 | $122 | $500 |
| Microscopic examination for white blood cells with manual cell count | 75 | $4 | $22 |
| Complete blood count (CBC), automated | 75 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 75 | $47 | $313 |
| Irrigation of implanted venous access drug delivery device | 69 | $17 | $114 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 68 | $90 | $657 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 68 | $330 | $1,722 |
| Carcinoembryonic antigen (cea) protein level | 60 | $19 | $99 |
| Administration of additional new drug or substance into vein using push technique | 58 | $39 | $289 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 57 | $1,109 | $4,802 |
| Infusion into a vein for hydration, each additional hour | 56 | $9 | $75 |
| Automated urinalysis | 55 | $2 | $16 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $25 | $145 |
| Office visit, established patient (10-19 min) | 50 | $36 | $150 |
| PSA test (prostate cancer screening) | 45 | $18 | $94 |
| New patient office visit (30-44 min) | 45 | $77 | $372 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 44 | $15 | $100 |
| Drawing of blood for a medical problem | 44 | $61 | $264 |
| Infusion, normal saline solution , 1000 cc | 41 | $2 | $19 |
| Unclassified drugs | 40 | $1 | $8 |
| New patient office visit (45-59 min) | 38 | $114 | $565 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 35 | $14 | $94 |
| Office visit, established patient, complex (40-54 min) | 19 | $137 | $496 |
| Initial hospital admission, moderate complexity | 19 | $100 | $470 |
| Infusion into a vein for hydration, 31-60 minutes | 18 | $25 | $256 |
| Injection of drug or substance into vein | 16 | $28 | $247 |
| Red blood count, automated test | 14 | $4 | $23 |
| New patient office visit, complex (60-74 min) | 14 | $168 | $709 |
| Flu vaccine administration | 12 | $30 | $58 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (78%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for hospitalist physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mangat is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (consulting-driven, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mangat experienced with oxaliplatin chemotherapy injection?
Does Dr. Mangat receive payments from pharmaceutical companies?
How do Dr. Mangat's costs compare to other hospitalist physicians in Midland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology